pharmaceutical care untuk pasien penyakit arthritis ... - Binfar Depkes

DAFTAR PUSTAKA1. The Facts about Arthritis, Arthritis Foundation 20062. Hansen K.E; Elliot M.E., Osteoarthritis, Pharmacotherapy, APathophysiological Approach, McGraw-Hill 20053. National Institute of Arthritis and Musculoskeletal and Skin Diseases,Handout on Health: Osteoarthritis, Bethesda MD, July 2002.4. NIH Conferece, Osteoarthritis : New Insights Part 1: The disease and itsRisk Factors,Annals of Internal Medicine , 17 Oct 2000.5. Zegaria M.A., Osteoarthritisin Seniors, Key Elements in DiseaseManagement, US Pharmacist 20066. Clegg, D.O., Efficacy of Glucosamine and Chondroitin Sulfate May Dependon Level of Osteoarthritis Pain, New England Journal of Medicine 20067. Altman R.D et al, Recommendations for the Medical Management ofOsteoarthritis of the Hip and Knee, American College of Rheumatology vol43, no9, 2000.8. Driskell C., et al, What You Need to Know About Arthritis, AmericanPhysical Therapy Association, 20069. American Geriatrics Society Panel on Exercise and Osteoarthritis, ExercisePrescription for Older Adults with Osteoarthritis Pain; The AmericanGeriatrics Society10. Drug Facts and Comparison, Acetaminophen, Wolters Kluwer Health, 200411. Golden BD, Abramson SB. Selective Cyclooxygenase-2 inhibitors. Rheum.Dis. Clin North Am 1999 May; 25(2)359-7812. Steinmeyer J. Pharmacological basis for therapy of pain and inflammationanti-inflammatory drugs, PubMed July 200013. Nice Appraisal Team, The Clinical effectiveness and cost effectiveness ofCelecoxib, The National Institute for Clinical Excellence, 1 Nov 200014. Stovitz SD, Johnson RJ, NSAID and Musculoskeletal Treatment, ThePhysician and Sport Medicine –Vol 31-N0 1-January 200315. Pray W.S., Consult Your Pharmacist-Osteoarthritis and OTC Therapies, USPharmacist ,199916. Setter S.M, Sonnet T.S ; New Treatment Option in the Management of GoutyArthritis, US. Pharmacist Nov1,2005